BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 31941781)

  • 1. B Cell-Specific Transcription Activator PAX5 Recruits p300 To Support EBNA1-Driven Transcription.
    Liu CD; Lee HL; Peng CW
    J Virol; 2020 Mar; 94(7):. PubMed ID: 31941781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Basis for Cooperative Binding of EBNA1 to the Epstein-Barr Virus Dyad Symmetry Minimal Origin of Replication.
    Malecka KA; Dheekollu J; Deakyne JS; Wiedmer A; Ramirez UD; Lieberman PM; Messick TE
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31142669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr Virus.
    Dheekollu J; Wiedmer A; Sentana-Lledo D; Cassel J; Messick T; Lieberman PM
    J Virol; 2016 Jun; 90(11):5353-5367. PubMed ID: 27009953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome Protein L4 is essential for Epstein-Barr Virus Nuclear Antigen 1 function.
    Shen CL; Liu CD; You RI; Ching YH; Liang J; Ke L; Chen YL; Chen HC; Hsu HJ; Liou JW; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2016 Feb; 113(8):2229-34. PubMed ID: 26858444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GAP31 from an ancient medicinal plant exhibits anti-viral activity through targeting to Epstein-Barr virus nuclear antigen 1.
    Shen CL; Huang WH; Hsu HJ; Yang JH; Peng CW
    Antiviral Res; 2019 Apr; 164():123-130. PubMed ID: 30817940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryo-EM Structure and Functional Studies of EBNA1 Binding to the Family of Repeats and Dyad Symmetry Elements of Epstein-Barr Virus
    Mei Y; Messick TE; Dheekollu J; Kim HJ; Molugu S; Muñoz LJC; Moiskeenkova-Bell V; Murakami K; Lieberman PM
    J Virol; 2022 Sep; 96(17):e0094922. PubMed ID: 36037477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and Functional Basis for an EBNA1 Hexameric Ring in Epstein-Barr Virus Episome Maintenance.
    Deakyne JS; Malecka KA; Messick TE; Lieberman PM
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Epstein-Barr virus OriP replication by poly(ADP-ribose) polymerase 1.
    Tempera I; Deng Z; Atanasiu C; Chen CJ; D'Erme M; Lieberman PM
    J Virol; 2010 May; 84(10):4988-97. PubMed ID: 20219917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replication licensing of the EBV oriP minichromosome.
    Hirai K; Shirakata M
    Curr Top Microbiol Immunol; 2001; 258():13-33. PubMed ID: 11443858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA ligand designed to antagonize EBNA1 represses Epstein-Barr virus-induced immortalization.
    Yasuda A; Noguchi K; Minoshima M; Kashiwazaki G; Kanda T; Katayama K; Mitsuhashi J; Bando T; Sugiyama H; Sugimoto Y
    Cancer Sci; 2011 Dec; 102(12):2221-30. PubMed ID: 21910783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleolin is important for Epstein-Barr virus nuclear antigen 1-mediated episome binding, maintenance, and transcription.
    Chen YL; Liu CD; Cheng CP; Zhao B; Hsu HJ; Shen CL; Chiu SJ; Kieff E; Peng CW
    Proc Natl Acad Sci U S A; 2014 Jan; 111(1):243-8. PubMed ID: 24344309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small molecule inhibition of Epstein-Barr virus nuclear antigen-1 DNA binding activity interferes with replication and persistence of the viral genome.
    Lee EK; Kim SY; Noh KW; Joo EH; Zhao B; Kieff E; Kang MS
    Antiviral Res; 2014 Apr; 104():73-83. PubMed ID: 24486954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. E2F1, ARID3A/Bright and Oct-2 factors bind to the Epstein-Barr virus C promoter, EBNA1 and oriP, participating in long-distance promoter-enhancer interactions.
    Boreström C; Forsman A; Rüetschi U; Rymo L
    J Gen Virol; 2012 May; 93(Pt 5):1065-1075. PubMed ID: 22302879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle-dependent EBNA1-DNA crosslinking promotes replication termination at oriP and viral episome maintenance.
    Dheekollu J; Wiedmer A; Ayyanathan K; Deakyne JS; Messick TE; Lieberman PM
    Cell; 2021 Feb; 184(3):643-654.e13. PubMed ID: 33482082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metaphase chromosome tethering is necessary for the DNA synthesis and maintenance of oriP plasmids but is insufficient for transcription activation by Epstein-Barr nuclear antigen 1.
    Sears J; Kolman J; Wahl GM; Aiyar A
    J Virol; 2003 Nov; 77(21):11767-80. PubMed ID: 14557661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient replication of Epstein-Barr virus-derived plasmids requires tethering by EBNA1 to host chromosomes.
    Hodin TL; Najrana T; Yates JL
    J Virol; 2013 Dec; 87(23):13020-8. PubMed ID: 24067969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr Nuclear Antigen 1 modulates replication of oriP-plasmids by impeding replication and transcription fork migration through the family of repeats.
    Aiyar A; Aras S; Washington A; Singh G; Luftig RB
    Virol J; 2009 Mar; 6():29. PubMed ID: 19265546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide analysis of host-chromosome binding sites for Epstein-Barr Virus Nuclear Antigen 1 (EBNA1).
    Lu F; Wikramasinghe P; Norseen J; Tsai K; Wang P; Showe L; Davuluri RV; Lieberman PM
    Virol J; 2010 Oct; 7():262. PubMed ID: 20929547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.